Literature DB >> 9364348

Long-term diazoxide treatment in persistent hyperinsulinemic hypoglycemia of infancy: a patient report.

F Darendeliler1, R Bundak, F Bas, N Saka, H Günöz.   

Abstract

Long-term diazoxide and somatostatin analogue have been used in the treatment of persistent hyperinsulinemic hypoglycemia of infancy albeit with some side effects. We report a case with persistent hyperinsulinemic hypoglycemia who has been on diazoxide therapy for 4.5 years. Diazoxide treatment maintained normoglycemia without causing any side effects, including hypertrichosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9364348     DOI: 10.1515/jpem.1997.10.1.79

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  2 in total

1.  The use of diazoxide in the management of spontaneous hypoglycemia in patients with ESRD.

Authors:  Bayan Mesmar; Megan Kristan; Medha Satyarengga; Elizabeth M Lamos; Rana Malek; Kashif M Munir
Journal:  CEN Case Rep       Date:  2020-04-09

Review 2.  Current Status of Childhood Hyperinsulinemic Hypoglycemia in Turkey.

Authors:  Zeynep Şıklar; Merih Berberoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.